How to Buy Merus Nv Stock
Merus Nv
Merus N. V. , a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands.
Merus Nv stock last closed at $54.61, down 1.41% from the previous day, and has decreased 5.27% in one year. It has overperformed other stocks in the Biotechnology industry by 0.71 percentage points. Merus Nv stock is currently +64.54% from its 52-week low of $33.19, and -13.29% from its 52-week high of $62.98.
At the moment, there are 69.21M shares of MRUS outstanding. The market value of MRUS is $3.78B. In the last 24 hours, 712,000 MRUS shares were traded.
How to Buy Merus Nv Stock
Wondering how to invest in Merus Nv stock? Here's how.
- Figure out where to buy Merus Nv stock: You need to pick a stock brokerage, but don't worry - we've tried dozens of stock brokerages and apps to help you determine where to buy Merus Nv stock.
- Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Deposit funds into your brokerage account: Choose your method of payment and add your details.
- Research Merus Nv stock: The Merus Nv ticker symbol is MRUS. Is Merus Nv stock a good investment? Should you buy shares of MRUS? How do MRUS's underlying business fundamentals look? Do top analysts think Merus Nv is a good buy? Why has MRUS's stock price moved recently? (Hint: Our stock research tools can help you evaluate if MRUS is a good stock to buy).
- Place your MRUS purchase: Decide if you will purchase MRUS shares at the current market price or use a limit order to purchase MRUS shares at a particular price.
- Get key alerts regarding your MRUS position: Create a watchlist to track your investment in Merus Nv shares.
Step 1: Figure out where to buy Merus Nv stock
You need a brokerage account to access the NASDAQ market and buy MRUS shares.
Our recommended brokerage: eToro
Based on our experience, eToro is the best online stock brokerage. eToro gives you:
- Invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to global financial markets: From Tech to Financial Services, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top stock exchanges.
- Social investing: eToro boasts a community with more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've picked the best brokerage, it's time to fill out some personal info so you can invest in MRUS today.
How to Create a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal info to open your new brokerage account.
- Send your data by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your brokerage account
Now that you have opened your account on the best stock trading app, you need to deposit funds:
Watch the tutorial below to see the process of depositing funds into your investment account.
Step 4: Research Merus Nv stock
Once you have decided on the best place to buy Merus Nv stock, it's crucial to research their stock before you invest, so you actually comprehend the risk as well as the opportunity.
Overview of key MRUS info
Merus Nv Due Diligence Score
WallStreetZen was built to help everyday investors perform more accurate fundamental analysis quickly.
You can see all of the due diligence checks on MRUS's stock page.
Is MRUS stock undervalued?
You can use a variety of different financial metrics, analyses, models, and charts to gauge MRUS's fair value.
Using relative valuations ratios:
- MRUS may be overvalued based on its P/B ratio of 6.34x, relative to Biotechnology industry P/B ratio of 4.66x
You can access additional valuation research on MRUS's stock here.
MRUS Financial Health Overview
Positive Health Checks:
- MRUS has a low debt to equity ratio of 0.23.
- There are more short-term assets than short-term liabilities on the MRUS balance sheet.
- There are more short-term assets than long-term liabilities on the MRUS balance sheet.
- MRUS has cash burn of 239683000. It has sufficient cash and short-term investments to cover this for at least one year.
- Total MRUS debt is lower than 5 years ago, relative to shareholder equity.
Negative Health Checks:
- MRUS has $458.33M in cash and short term investments. This is not enough to cover its annual cash burn of $239.68M.
- MRUS profit margin has gone down from -323.7% to -408.5% in the past year.
Is MRUS stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 7 sell side analysts who give recommendations on MRUS, the consensus analyst rating on MRUS is a Strong Buy
Please note that analyst ratings are not stock recommendations, nor are they investment advice.
Latest MRUS Analyst Recommendations
Andrew Fein, a top 5% analyst from HC Wainwright & Co. reiterates MRUS with a buy rating and maintains their MRUS price target from $85.00 to $85.00, on Mar 3, 2025.
Joseph Catanzaro, a bottom 4% analyst from Piper Sandler initiates coverage on MRUS with a strong buy rating and announces their MRUS price target of $84.00, on Feb 13, 2025.
You can dive deeper into what analysts are projecting on the Merus Nv stock forecast page.
MRUS Trading Indicators
MRUS Revenue
Last year, MRUS revenue was $67.89M. During the last 5 year, MRUS's revenue has increased by 18.87% per year. This was slower than the Biotechnology industry average of 43.24%.
You can analyze MRUS's earnings and revenue performance here.
Latest Insiders Trades at MRUS
Over the past year, insiders at MRUS have bought more shares than they have sold.
Sven Ante Lundberg, President CEO PEO of MRUS, was the latest MRUS insider to buy. They bought $47,614.38 worth of MRUS shares on Apr 17, 2025.
Research more about who owns MRUS shares here.
Can I rely on MRUS as an income stream?
No, Merus Nv doesn't provide an income stream by paying out dividends.
What do other traders have to say about MRUS?
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Place your MRUS purchase
There are two primary order types:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are usually fine for most investors. - Limit order: A limit order lets you buy or sell a stock at a specific price (or better).
If you want to be certain you're buying or selling at a specific dollar amount limit, place a limit order.
Click the Open Trade button and eToro will execute your order.
If you require additional help buying stocks on eToro, watch the helpful video below:
Step 6: Get key alerts regarding your MRUS position
Now that you own some MRUS shares, you'll want to keep up with your investment.
Add MRUS to a watchlist to track the most important metrics related to your MRUS stock.
MRUS Feed
How to Buy Stock in Merus Nv
To reiterate, here are the 6 steps to buy Merus Nv stock:
- Figure out where to buy Merus Nv stock
- Sign up for a brokerage account
- Deposit funds into your brokerage account
- Research Merus Nv stock
- Place your MRUS purchase
- Get key alerts regarding your MRUS position
If you require a online brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to get the latest news on your investment in Merus Nv, create a watchlist on WallStreetZen today.
More "How To" Guides You May Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.